Influence of Highly Active Antiretroviral Therapy on the Outcome of Subclinical Visceral Leishmaniasis in Human Immunodeficiency Virus-Infected Patients
Open Access
- 15 February 2001
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 32 (4) , 633-635
- https://doi.org/10.1086/318708
Abstract
Seventeen human immunodeficiency virus-infected patients who were harboring untreated subclinical visceral leishmaniasis (VL) were prospectively followed up. None of the 11 patients who received highly active antiretroviral therapy (HAART) presented with symptomatic VL during follow-up, whereas 2 out of 6 patients who received therapy other than HAART had an episode of overt kala-azar. These findings suggest that HAART does not induce the evolution of latent VL into symptomatic disease.Keywords
This publication has 10 references indexed in Scilit:
- Immune reconstitution in HIV-1 infected subjects treated with potent antiretroviral therapySexually Transmitted Infections, 1999
- Visceral leishmaniosis in HIV-positive patientsAIDS, 1998
- Leishmaniosis – new perspectives on an underappreciated opportunistic infectionAIDS, 1998
- HIV combination therapyAIDS, 1998
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- Effect of HAART on natural history of AIDS-related opportunistic disordersThe Lancet, 1998
- Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 diseaseThe Lancet, 1998
- A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or LessNew England Journal of Medicine, 1997
- Cytomegalovirus retinitis after initiation of highly active antiretroviral therapyThe Lancet, 1997
- Is leishmaniasis ever cured?Transactions of the Royal Society of Tropical Medicine and Hygiene, 1992